The Guild Pharmacy Academy has launched another new online course to assist pharmacists in meeting their continuing professional development requirements.
The Academy has partnered with Bayer Australia to develop an online learning course which examines the use of the anticoagulant drug Xarelto (rivaroxaban).
The course gives pharmacists an understanding of the puprose and benefits of anticoagulant therapy in non-valvular atrial fibrillation and venous thromboembolism.
Completion of the course attracts 2 Group Two CPD credits - for details see www.myCPD.org.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Sep 16